Flow cytometric test for beryllium sensitivity
Open Access
- 14 June 2004
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 60B (1), 23-30
- https://doi.org/10.1002/cyto.b.20015
Abstract
Background Chronic beryllium disease (CBD) is an occupational granulomatous disorder characterized by hypersensitivity to beryllium, mediated by CD4+ T lymphocytes, and predominantly affects the lungs. In this disorder, lymphocyte proliferative responses to beryllium, measured by 3H thymidine incorporation, are used for diagnosis of CBD, for screening asymptomatic workers or former workers to detect unrecognized disease, and for surveillance as a bioassay to detect abnormal exposures. Problems with test variability and the use of radioactivity have recently led to the search for alternative methods. Methods We applied a 5,6‐carboxyfluorescein diacetate succinimidyl ester flow cytometric technique for measurement of mitogen‐ and antigen‐induced T‐lymphocyte proliferation to a group of beryllium‐exposed sensitized individuals and beryllium‐unexposed controls. Results We detected mitogen and antigen proliferative responses in CD3+, CD4+, and CD8+ subpopulations. Phytohemagglutinin and Candida stimulated CD4+ and CD8+ T‐cell responses, but beryllium appeared to stimulate only CD3+/CD4+ responses. Conclusions This technique may provide a sensitive, nonradioactive alternative to the traditional proliferation tests that measure beryllium sensitivity. It offers the added specificity of enabling phenotypic description of the responding cell type and may prove to be easier to standardize for clinical use.Keywords
This publication has 38 references indexed in Scilit:
- HLA-DP-unrestricted TNF- release in beryllium-stimulated peripheral blood mononuclear cellsEuropean Respiratory Journal, 2002
- A Comparison and Critique of Historical and Current Exposure Assessment Methods for Beryllium: Implications for Evaluating Risk of Chronic Beryllium DiseaseApplied Occupational and Environmental Hygiene, 2001
- Contribution of Incidental Exposure Pathways to Total Beryllium ExposuresApplied Occupational and Environmental Hygiene, 2001
- Candida‐Specific Systemic Cell‐Mediated Immune Reactivities in Human Immunodeficiency Virus–Positive Persons with Mucosal CandidiasisThe Journal of Infectious Diseases, 2001
- Beryllium, an Adjuvant That Promotes Gamma Interferon ProductionInfection and Immunity, 2000
- Chronic beryllium disease: diagnosis and management.Environmental Health Perspectives, 1996
- Chronic Beryllium Disease—From the Workplace to Cellular Immunology, Molecular Immunogenetics, and BackClinical Immunology and Immunopathology, 1994
- HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium DiseaseScience, 1993
- Screening Blood Test Identifies Subclinical Beryllium DiseaseJournal of Occupational and Environmental Medicine, 1989
- Maintenance of Alveolitis in Patients with Chronic Beryllium Disease by Beryllium-Specific Helper T CellsThe New England Journal of Medicine, 1989